Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency

Name: Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency
Creator: Division of Internal Medicine, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Department of Biomedical and Clinical Sciences "Luigi Sacco," Università degli Studi di Milano, Milan, Italy
Published: 2024-02-02T00:00:00+08:00

Zenodo2024-02-02 更新2026-04-07 收录

药物疗效评估

获得性C1抑制剂缺乏性血管性水肿

数据链接：

https://zenodo.org/doi/10.5281/zenodo.10610637 数据链接链接失效反馈

官方服务：

资源简介：

Suffritti C, Sartorio S, Berra S, Janu VP, Caccia S, Zanichelli A. Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2023 Mar;11(3):963-965.e1. doi: 10.1016/j.jaip.2022.10.041. Epub 2022 Nov 13. PMID: 36379410.

提供机构：

Division of Internal Medicine, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Department of Biomedical and Clinical Sciences "Luigi Sacco," Università degli Studi di Milano, Milan, Italy

创建时间：

2024-02-02